Navigation Links
Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China
Date:8/6/2014

WOODBRIDGE, ON, August 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that it has entered into a Memorandum of Understanding to create a Joint Venture Distribution Agreement with ACGT Corporation  ("ACGT") and associates.   A leader in Canada's DNA services industry with extensive ties to China, ACGT will identify and introduce Pivotal to potential partners for the commercialization of its products in China.

ACGT was founded by Dr. Hai Shiene Chen in 1995 and is a privately owned provider of oligonucleotide synthesis and DNA sequencing services to customers in the Greater Toronto Area and across Canada.  ACGT is considered to be one of the prominent Canadian providers of DNA services. ACGT has consistently been selected as the primary service supplier with superior quality control and fast delivery time for many well-known medical institutions. 

"Business in the life sciences and healthcare sector in China is growing increasingly robust," said Dr. Chen, ACGT's President and CEO. "ACGT understands the challenges of navigating the route for the Chinese marketplace.  With China expected to move to a new phase as the world's largest market within this decade, we have relationships with the right partners to help capitalize on the many opportunities in China now and into the future."

"With ACGT's track record for success and its strong relationships with pharmaceutical companies and oth
'/>"/>

SOURCE Pivotal Therapeutics Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data
2. BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy
3. Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference
4. Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
5. Shield Therapeutics ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease
6. FDA Grants Approval of IND to Commence a Phase 3 Pivotal Study for ST10 for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease
7. Reversal of Fate: Hisense Medical Equipment Pivotal in Saving of a Two-year-old Child with Liver Cancer
8. Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Menieres Disease
9. Siltuximab Pivotal Trial Data Show Efficacy for Treatment of Patients with Multicentric Castlemans Disease
10. Seno Medical Instruments Launches Pivotal Study of New Functional Imaging Platform in Breast Cancer Diagnosis
11. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- According to a new market research ... Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species ... Users - Global Forecast to 2020", published by MarketsandMarkets, the ... $736.85 Million by 2020 from $452.36 Million in 2015, ... Browse 71 market data Tables and 90 Figures spread ...
(Date:5/22/2015)... DUBLIN , May 22, 2015 Research ... announced the addition of the "Latest Regulations ... report to their offering. This ... officially issued a guidance on international multi-center clinical ... , which has begun to be implemented on ...
(Date:5/22/2015)... -- Richmond Pharmacology is a university ... worldwide reputation for excellence in clinical trials. It ... reviewed medical journals. Its officers are engaged with ... about rules for transparency and publication of clinical ... Clinical research is conducted worldwide, therefore ...
Breaking Medicine Technology:Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... Md. , May 26 The U.S. Food and Drug Administration ... liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... The FDA has approved a ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced it will present at ... on June 9, 2010 , in New York, NY . ... provide an update on the Company,s marketed products and clinical programs. , ... The presentation will be webcast. To access ...
Cached Medicine Technology:FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli 2FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli 3ISTA Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference 2
(Date:5/22/2015)... May 22, 2015 Memorial Day weekend is ... Insurance is offering some tips to help promote safe ... there will be 383 traffic fatalities this Memorial Day weekend. ... National Highway Traffic Safety Association: , , ... vehicle is wearing a seatbelt, whether they’re driving or riding ...
(Date:5/22/2015)... PA (PRWEB) May 22, 2015 According to ... a hub for drug related death, totaling almost 2,500 confirmed ... as reported by state officials, totals 2,489 deaths stemming from ... work out, Pennsylvania loses seven people every day to fatal ... has been singled out as one of the most rife ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President ... selected by Consulting-Specifying Engineer (CSE) magazine as a young ... in the May/June issue of the publication. , This ... 40 and younger who have, and continue to make ... in other areas of their professional and personal endeavors. ...
(Date:5/22/2015)... 22, 2015 Puritan Medical Products, ... the medical, diagnostic, environmental, and forensics industries celebrates ... products in the US. At a time when ... the US, Puritan remains committed to designing and ... Guilford, Maine facility. , Since 1919, Puritan has ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... 14 (HealthDay News) -- In black Americans with type ... eye,s retina (retinal arteriolar narrowing) is associated with increased ... "Retinal arteriolar narrowing has long been described as one ... pressure] and cardiovascular disease," Dr. Monique Roy, of the ...
... A new study from the Regenstrief Institute and Indiana ... dementia are more likely to be living at home than ... that most individuals with dementia in the United States eventually ... Care for Older Adults With and Without Dementia" appears online ...
... , MONDAY, May 14 (HealthDay News) -- People ... significant improvement in the first six weeks, but may still ... a new study. Researchers analyzed data from 33 studies ... how treatment affects low-back pain. Their findings appear in the ...
... Using tiny solar-panel-like cells surgically placed underneath the retina, ... a system that may someday restore sight to people who ... diseases. This device a new type of retinal ... are equipped with a miniature camera and a pocket PC ...
... MI (May 9, 2012): Newly published results from a ... under development by Hygieia, Inc., demonstrate DIGS, potential to ... 2 or type 1 diabetes. DIGS automatically adjusted insulin ... Over the 12-week intervention period of the study, investigators ...
... May 11 (HealthDay News) -- A type of therapy that ... children but not severely obese teens, new research suggests. ... male) aged 6 to 16, who began "behavioral treatment" for ... method for assessing weight data that took into account the ...
Cached Medicine News:Health News:Individuals with dementia more likely to die at home than in nursing homes 2Health News:Back Pain Therapy Often Yields Early Benefits: Study 2Health News:New type of retinal prosthesis could better restore sight to blind, Stanford study says 2Health News:New type of retinal prosthesis could better restore sight to blind, Stanford study says 3Health News:New type of retinal prosthesis could better restore sight to blind, Stanford study says 4Health News:Automated insulin dosage titration system demonstrates positive clinical study results 2Health News:Sooner Is Better for Controlling Obese Kids' Weight: Study 2
... Post Operative Pin® Knee Brace (DxHDDLP) has a ... drop lock lever and laminate liner. The precision ... brace from migrating on the leg during ambulation. ... that controls flexion and extension in 5° increments ...
... Neuroprene™ soft supports are a convenient, ... proprioceptive taping for common orthopedic conditions/instabilities. ... provide specific compression and lateral to ... (proprioceptors) in the skin and soft ...
... The Drytex Adjustable Patella Donut ... a unique nylon core and polyester ... airflow. A trimable full-circumference donut provides ... who have neoprene based allergies or ...
... for total knees, meniscus repairs, regenerative chondroplasty, ... TROM gives easy-to-use range of motion control ... Rehab TROM can be used as a ... purchased separately be used with the TROM ...
Medicine Products: